Crnkic, M., Månsson, B., Larsson, L., Geborek, P., Heinegård, D., & Saxne, T. (2003). Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. BioMed Central.
Citação norma ChicagoCrnkic, Meliha, Bengt Månsson, Lotta Larsson, Pierre Geborek, Dick Heinegård, and Tore Saxne. Serum Cartilage Oligomeric Matrix Protein (COMP) Decreases in Rheumatoid Arthritis Patients Treated With Infliximab or Etanercept. BioMed Central, 2003.
MLA citiranjeCrnkic, Meliha, et al. Serum Cartilage Oligomeric Matrix Protein (COMP) Decreases in Rheumatoid Arthritis Patients Treated With Infliximab or Etanercept. BioMed Central, 2003.
Opozorilo: Ti citati niso vedno 100% točni.